Related Experiment Video
Updated: Aug 3, 2026
08:43
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Published on: March 10, 2017
High Throughput Screening for Drug Discovery: Continually Transitioning into New Technology
Fox1, Farr-Jones, Yund
1HighTech Business Decisions, Moraga, CA.
Journal of Biomolecular Screening
|June 6, 2000
Summary
High-throughput screening (HTS) labs need larger compound libraries and faster, automated systems to discover drug leads efficiently. Emerging technologies like microfluidics and virtual screening are key to meeting these demands in drug discovery.
Area of Science:
- Drug discovery and development
- Biotechnology and pharmaceutical sciences
Background:
- High-throughput screening (HTS) laboratories face pressure to increase drug lead discovery while managing costs.
- This necessitates larger compound sets and more efficient screening methodologies.
Purpose of the Study:
- To explore the evolving technological landscape and integrated solutions supporting HTS in drug discovery.
- To identify key enabling technologies that enhance the speed and efficiency of screening processes.
Main Methods:
- Review of current trends and enabling technologies in HTS.
- Analysis of supplier collaborations for integrated equipment and consumables.
- Evaluation of specific technologies such as miniaturization, microfluidics, and advanced assay formats.
Main Results:
- Continuous development of enabling technologies for HTS.
- Increased collaboration between suppliers to offer integrated solutions.
- Adoption of diverse tools including microfluidic chips, subnanoliter dispensing, and virtual screening.
Conclusions:
- HTS experts are actively evaluating and integrating new technologies to optimize drug discovery operations.
- Technological advancements are crucial for meeting the demands of cost-effective and high-volume drug lead identification.
Related Concept Videos
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...